Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nanodiamond delivery circumvents tumor resistance to doxorubicin.

Literature DB >> 21532613

Nanodiamond delivery circumvents tumor resistance to doxorubicin.

Xiao-wei Ma¹, Yu-liang Zhao, Xing-jie Liang.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2011 PMID： 21532613 PMCID： PMC4002519 DOI： 10.1038/aps.2011.58

Source DB: PubMed Journal: Acta Pharmacol Sin ISSN： 1671-4083 Impact factor: 6.150

× No keyword cloud information.

12 in total

Review 1. High-time chemotherapy or high time for low dose.

Authors: B A Kamen; E Rubin; J Aisner; E Glatstein
Journal: J Clin Oncol Date: 2000-08 Impact factor: 44.544

2. Selective targeting of green fluorescent nanodiamond conjugates to mitochondria in HeLa cells.

Authors: Msaukiranji Mkandawire; Andrea Pohl; Tatiana Gubarevich; Victoria Lapina; Dietmar Appelhans; Gerhard Rödel; Wolfgang Pompe; Jürgen Schreiber; Jörg Opitz
Journal: J Biophotonics Date: 2009-10 Impact factor: 3.207

3. Wet chemistry route to hydrophobic blue fluorescent nanodiamond.

Authors: Vadym N Mochalin; Yury Gogotsi
Journal: J Am Chem Soc Date: 2009-04-08 Impact factor: 15.419

4. Mechanisms of multidrug resistance in cancer.

Authors: Jean-Pierre Gillet; Michael M Gottesman
Journal: Methods Mol Biol Date: 2010

Review 5. Multidrug resistance in breast cancer: mechanisms, strategies.

Authors: G Giaccone; S C Linn; H M Pinedo
Journal: Eur J Cancer Date: 1995 Impact factor: 9.162

6. Acute cardiac toxicity in patients after doxorubicin treatment and the effect of combined tocopherol and nifedipine pretreatment.

Authors: R Lenzhofer; U Ganzinger; H Rameis; K Moser
Journal: J Cancer Res Clin Oncol Date: 1983 Impact factor: 4.553

7. Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment.

Authors: Edward K Chow; Xue-Qing Zhang; Mark Chen; Robert Lam; Erik Robinson; Houjin Huang; Daniel Schaffer; Eiji Osawa; Andrei Goga; Dean Ho
Journal: Sci Transl Med Date: 2011-03-09 Impact factor: 17.956

Review 8. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs.

Authors: R Krishna; L D Mayer
Journal: Eur J Pharm Sci Date: 2000-10 Impact factor: 4.384

Nanodiamond delivery circumvents tumor resistance to doxorubicin.

Review 1. High-time chemotherapy or high time for low dose.

2. Selective targeting of green fluorescent nanodiamond conjugates to mitochondria in HeLa cells.

3. Wet chemistry route to hydrophobic blue fluorescent nanodiamond.

4. Mechanisms of multidrug resistance in cancer.

Review 5. Multidrug resistance in breast cancer: mechanisms, strategies.

6. Acute cardiac toxicity in patients after doxorubicin treatment and the effect of combined tocopherol and nifedipine pretreatment.

7. Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment.

Review 8. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs.

9. MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis.

10. Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells.

Review 1. Multifunctional nanodiamonds in regenerative medicine: Recent advances and future directions.

2. Nuclear mapping of nanodrug delivery systems in dynamic cellular environments.

3. Solid-phase synthesis, characterization, and cellular activities of collagen-model nanodiamond-peptide conjugates.

4. The biocompatibility of nanodiamonds and their application in drug delivery systems.

Review 5. Role of Nanodiamonds in Drug Delivery and Stem Cell Therapy.